ArticleTranslational pediatrics2026
Blood-based inflammatory parameters and machine learning models for mortality prediction in critically ill pediatric pneumonia: a retrospective cohort study.
Article in Translational pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Pneumonia remains a leading cause of morbidity and mortality in critically ill children, yet comprehensive prognostic biomarkers specifically validated in pediatric intensive care settings remain limited. Identifying readily available blood parameters that predict mortality risk could enhance early risk stratification and guide therapeutic interventions. This study aimed to evaluate the prognostic value of blood parameters for hospital mortality in critically ill pediatric pneumonia patients and develop machine learning (ML)-based predictive models. Methods: This retrospective cohort study analyzed pediatric pneumonia patients (aged 3 months to 18 years) admitted to intensive care units for ≥24 hours from the Pediatric Intensive Care (PIC) database version 1.1. Multivariate Cox regression analyses assessed associations between blood parameters and hospital mortality, adjusting for age, gender, bacterial infection status, and pathogen detection. Restricted cubic spline analyses examined dose-response relationships. Six ML algorithms incorporating significant blood parameters and clinical covariates were developed and validated using 7:3 train-test split. Results: A total of 606 children were included, with an overall hospital mortality of 14.4% (87/606). Multivariate Cox regression identified three significant prognostic factors: neutrophil percentage adjusted hazard ratio (HR): 1.017, 95% confidence interval (CI): 1.004-1.031, P=0.01], lymphocyte percentage (adjusted HR: 0.985, 95% CI: 0.970-0.999, P=0.04), and platelet-to-neutrophil ratio (PNR) (adjusted HR: 0.995, 95% CI: 0.989-1.000, P=0.04). Restricted cubic spline analyses revealed predominantly linear or U-shaped dose-response relationships. Among ML models, random forest demonstrated superior predictive performance with test area under the curve (AUC) of 0.877 (95% CI: 0.860-0.895), sensitivity of 80.9%, specificity of 79.1%, and accuracy of 79.5%. The model significantly outperformed individual blood parameters (neutrophil percentage AUC: 0.712; lymphocyte percentage AUC: 0.660; PNR AUC: 0.689), and decision curve analysis confirmed positive net benefit across threshold probabilities of 5-50%. Conclusions: Neutrophil percentage, lymphocyte percentage, and PNR are independent prognostic indicators for mortality in critically ill pediatric pneumonia. ML-based models incorporating these parameters show promise for early mortality risk stratification in pediatric intensive care settings.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.